Meanwhile, demand for vaccines targeting respiratory syncytial virus are down in the U.S. Also, if you are uncertain about whether you might have covid or the flu, the newly approved at-home Healgen ...

Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company focused on precision oncology through synthetic lethality, today announced that it has engaged Philippe ...

Looking at a slightly longer term, the performance of PFE stock with respect to the index has been quite volatile in recent ...

London: Pfizer recently achieved a significant legal victory by winning bid in a London court to invalidate two patents held ...

The global atorvastatin calcium market is experiencing growth due to an increase in the cardiovascular disease population and the availability of generic products is expected to drive the growth of ...

The global anti-osteoporosis therapy and fracture healing market is poised for remarkable growth, with projections indicating a rise from USD 14,051.6 million in 2023 to USD 22,427.6 million by 2033, ...

The global genital herpes treatment market is on an impressive growth trajectory, with recent projections indicating substantial expansion over the next decade. Valued at USD 2.14 billion in 2023, the ...

ViiV Healthcare to triple annual supply of long-acting HIV PrEP for low- and middle-income countries: London, UK Wednesday, October 9, 2024, 12:00 Hrs [IST] GSK plc announced that ...

This report highlights major developments in the health sector, including WeightWatchers offering a new obesity drug, Danco ...

U.S. sales of RSV vaccines from GSK and Pfizer are down significantly after regulators narrowed the targeted age group and ...

DelveInsight's CD47 Inhibitors Market Insights report includes a comprehensive understanding of current treatment practices, ...

Current health news highlights WeightWatchers offering a compound version of Novo Nordisk's obesity drug, Danco seeking FDA ...